These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17684854)

  • 21. Assessment of cardiovascular risk factors and their correlation in 28,000 Hungarians.
    Simay A; Lakatos Z; Ilyes I; Jancso Z
    Public Health; 2005 May; 119(5):437-41. PubMed ID: 15780334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Patients with the highest cardiovascular risk are the least compliant with their antihypertensive therapy (DESIR study)].
    Aumont MC; Allaert FA; Garnier L
    Arch Mal Coeur Vaiss; 2006; 99(7-8):736-41. PubMed ID: 17061455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors in cardiovascular diseases in a semi-urban community of the Tunisian Sahel].
    Ghannem H; Limam K; Ben Abdelaziz A; Mtiraoui A; Hadj Fredj A; Marzouki M
    Rev Epidemiol Sante Publique; 1992; 40(2):108-12. PubMed ID: 1631375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension awareness, treatment, and control in chronic kidney disease.
    Sarafidis PA; Li S; Chen SC; Collins AJ; Brown WW; Klag MJ; Bakris GL
    Am J Med; 2008 Apr; 121(4):332-40. PubMed ID: 18374693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination patterns of cardiovascular risks and sequelae at different stage of hypertension in natural hypertensive population in Beijing.
    Guo XH; Zhang PH; Zeng ZC; Wang W; Li C; Shi Y; Liu ZJ
    Clin Exp Hypertens; 2009 Apr; 31(2):142-55. PubMed ID: 19330603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factor control in treated hypertensives from Estonia and Sweden. Why the difference?
    Nilsson PM; Journath G; Palm K; Viigimaa M
    Blood Press; 2007; 16(5):301-4. PubMed ID: 17934917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
    Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
    Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polypharmacotherapy in the elderly hypertensive patient].
    Alvarez A; Clara JG
    Rev Port Cardiol; 1994; 13(7-8):587-92, 563. PubMed ID: 7917404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 34. [Predictors of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jul; 25(145):9-14. PubMed ID: 18839606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians.
    Amira CO; Okubadejo NU
    Niger Postgrad Med J; 2007 Dec; 14(4):325-9. PubMed ID: 18163143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Smoking and other risk factors of cardiovascular diseases, connected with arteriosclerosis among youth].
    Chmiel-Połeć Z; Cybulska I
    Przegl Lek; 2008; 65(10):437-45. PubMed ID: 19189518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution of cardiovascular risk factors in coronary patients in Sahel, Tunisia].
    Lihioui M; Boughzala E; Ben Farhat M; Ammar H; Chaouech A; Jemaa R; Kaabachi N
    East Mediterr Health J; 2007; 13(3):536-43. PubMed ID: 17687825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness, treatment and control of hypertension in Denmark. The Inter99 study.
    Sehestedt T; Ibsen H; Jørgensen T
    Blood Press; 2007; 16(5):312-9. PubMed ID: 17852094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of persistence with antihypertensive therapy: results from the NHANES.
    Bautista LE
    Am J Hypertens; 2008 Feb; 21(2):183-8. PubMed ID: 18188161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.